Delivery Order SPE2DB22D3102-SPE2DB26FK8TH
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Plaquenil 200 mg tablets (100-count units) with a contract value of $1,318.08. This firm fixed-price delivery order, which has no set-aside designation, is scheduled for completion by September 11, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a $199.02 firm fixed price delivery order contract to supply 4561475224 PLAQUENIL 200 MG TABLET 100S. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to its place of performance in Conshohocken, Pennsylvania within the one day period of July 12-13, 2023. The Defense Logistics Agency routinely issues delivery orders against various pharmaceutical distribution contracts to support the...
- The U.S. Defense Logistics Agency (DLA) awarded a $49,486.13 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Plaquenil 200 mg tablets. The contract has a period of performance through June 23, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of pharmaceutical products and medical supplies...
- The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a firm fixed price delivery order valued at $318.24 to supply 100 tablets of Plaquenil 200 mg. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to its Conshohocken, Pennsylvania facility by August 25, 2023 under the terms of the contract. No major subcontractors or set aside designations were indicated. The Defense Logistics Agency routinely issues delivery orders against various...
- The Defense Logistics Agency awarded a delivery order to Amerisourcebergen Drug Corporation for the purchase of one hundred tablets of Plaquenil 200 mg, with a potential value of twenty-six dollars. The delivery order was awarded on October 19, 2023 under Amerisourcebergen's corporate office blanket purchase agreement and has a completion date of October 20, 2023. The delivery order was awarded on a firm-fixed-price basis for delivery to a location in Conshohocken, Pennsylvania, with no...
- The Defense Logistics Agency awarded a $320,580 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 100 units of Plaquenil 200 mg tablets. As one of the largest medical/surgical prime vendors for the Department of Defense, Amerisourcebergen will deliver the pharmaceutical products from its facility in Conshohocken, Pennsylvania to an unknown customer by August 1, 2023 under contract number 4561652713. The order was placed utilizing the Medical/Surgical Prime...
- The Defense Logistics Agency awarded a $8,771 delivery order to Amerisourcebergen Drug Corporation for 200mg Plaquenil tablets. Under this firm fixed price contract, Amerisourcebergen will supply 100 tablets of the specified medication to an address in Conshohocken, Pennsylvania, with performance required between August 4-7, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this award supports DLA's mission to provide critical products and services...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at three thousand seven hundred eighty-five dollars and eighty-four cents ($3,785.84) to Amerisourcebergen Drug Corporation for the provision of two hundred (200) tablets of Plaquenil, a malaria drug. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with work scheduled to be completed by July 20, 2023 under the contract start date of July 19, 2023. No...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,706.79 delivery order contract is for the supply of Plaquenil 200 mg tablets. The contract has an ultimate completion date of April 5, 2023 and is a firm fixed price arrangement. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Plaquemin 200 mg tablets (100-count packages) under a firm fixed-price contract with a ceiling value of $1,510.42. The order, issued on August 1, 2025, with an ultimate completion date of August 4, 2025, represents a competitively awarded, non-set-aside procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this...
- SPE2DB22D3102Indefinite Delivery Contract
- SPE2DB22D3102-SPE2DB26FK8THDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Plaquenil 200 mg tablets (100-count) with a ceiling value of $7,957.92. This is a firm fixed-price delivery order with an ultimate completion date of October 31, 2025, and represents a non-set-aside competitive award. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen, a major pharmaceutical distributor and critical federal medical procurement vendor, demonstrates significant capability in fulfilling government healthcare requirements through its extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains, consistently delivering orders through open competition with firm fixed pricing arrangements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.0k | 10/30/25 |